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Abstract
Background: The clear cell/signet-ring cell variant of cutaneous squamous cell carcinoma (cSCC) is extremely rare.
Its carcinogenesis has consistently been linked to ultraviolet radiation and HPV in the literature. However, there is
little definite information about the contribution of diabetes mellitus (DM) to cSCC.
Case presentation: A 78-year-old Chinese woman with type 2 DM presented with a mushroom-like lump in her right
thigh. Histological findings revealed that the lesion was mainly composed of clear cells and signet-ring cells. The septa
of vacuoles in cytoplasm displayed positivity for periodic acid schiff (PAS) and cytokeratins such as AE1/AE3, CK5/6,
CK14, and CK19. Malignant cells did not express CK7, CK8, CK18, CK20, p16, p53, or c-erbB-2, and the Ki-67 index was
less than 5 %. We further explored the etiology of clear cell/signet-ring cell cSCC using human papillomavirus (HPV)
type-specific PCR and genotyping and confirmed that the patient was not infected with HPV. Nucleus positivity for p63
indicated the involvement of the p53 family in the lesion. Meanwhile, the expression of fibroblast growth factor
receptor-2 (FGFR2), a downstream effector of p63, was upregulated in tumor cells.
Conclusions: This study provides the first report on the clear cell/signet-ring cell variant of cSCC found in the right
thigh of a patient with type 2 DM. Metabolic imbalance in addition to conventional pathogens such as UV and HPV
may contribute to the development of the lesion via p63/FGFR2 axis.
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Background
The clear cell/signet-ring cell morphology has historic-
ally been considered to be a feature of mucin-producing
adenocarcinoma in the literature. Primary cutaneous
squamous cell carcinomas (cSCC) with clear cell/signet-
ring cell morphology are very rare and have always been
reported in sun-exposed regions of the body, such as the
head and neck [1]. The phrase “clear cell” refers to cells
characterized by hydropic cytoplasm, and “signet-ring
cell” is used to describe cells characterized by eccentric
nuclei that are located near the cellular border by large
cytoplasmic vacuoles [2]. Among cutaneous carcinomas,
the existence of the clear cell/signet-ring cell provides a
basis for differential diagnosis, ruling out a variety of ad-
nexal tumors [3, 4].
The exact etiology of the clear cell/signet-ring cell vari-
ant of cSCC is largely unknown. A main pathogen for cu-
taneous SCC is exposure to ultraviolet (UV) radiation,
since more than 80 % of these tumors appear on sun-
exposed parts of body [5]. Human papillomaviruses
(HPVs) from the β genus are suspected to act as a co-
carcinogen with UV. An early region of the HPV genome
encodes five or six early non-structural proteins, including
E1, E2, E4, E5, E6 and E7 [6]. The High-risk HPV proteins
E6 and E7 are able to promote malignant transformation
of squamous cells by degrading the tumor suppressor p53
[7]. The risk for developing cSCC appears to be 65–250
times higher in immunosuppressed patients, especially
organ transplant recipients (OTR) [8].
Although the precise molecular mechanisms are still
the subject of controversy, several lines of evidence sug-
gest a close relationship between diabetes mellitus (DM)
and many tumors including those of the pancreas, liver,
and breast [9–11]. Recent studies have provided sub-
stantial evidence that DM may contribute to the patho-
genesis of cSCC. Primary cSCC presenting as chronic
diabetic foot ulcers has been proposed as a complication
of DM [12–15]. More recently, a elaborate study demon-
strated that oral SCC in DM patients was associated
with poorer prognoses compared to oral SCC in non-
DM patients [16]. Furthermore, oral administration of
metformin, a traditional anti-DM drug, can significantly
improve the overall survival of DM patients with head
and neck cSCC [17]. In this study, we report the first
case of cutaneous SCC with clear cell/signet-ring cell
morphology found in the right thigh of a woman with
type 2 DM. Immunohistochemistry and HPV type-
sepcific PCR and genotyping were employed to explore
the possibly underlying mechanisms.
Case presentation
A 78-year-old Chinese woman, gravida 2, para 2, with
menopause at age 51, presented to the Department of
Endocrinology with a 2-week history of 5 × 3 × 1.5 cm
mushroom-like lump in her right thigh (Fig. 1a, b). Ac-
cording to the medical history, the patient was a house-
wife and confirmed that she was not exposed to
excessively professional, accidental, or medical UV radi-
ation. She had a 30-year history of type 2 DM and her
HbA1c was 8.4 % (68mMol/mol) upon admission. There
were several scars caused by chronic ulcers adjacent to
the lesion (Fig. 1a). She denied any history of neoplasms.
The lesion was resected under local anesthesia. The
sample was fixed in 4 % buffered formalin and embedded
in paraffin using conventional techniques. Serial tissue
sections were studied using hematoxylin and eosin stain-
ing, histochemistry, immunohistochemistry (Table 1), and
HPV type-specific PCR and genotyping. Blind evaluation
of all results was performed by two independent
pathologists.
Histopathology
Light microscopy examination showed that the lesion
was mainly composed of malignant clear cells and
signet-ring cells arranged in thick trabeculae or solid
nests (Fig. 1c). The clear cells contained prominent vac-
uoles which were sharply demarcated and appeared
empty. Each of the signet-ring cells contained a large
cytoplasmic vacuole and an eccentric nucleus (Fig. 1d).
Atypical mitotic figures were plentiful.
Immuno- and histochemistry
Periodic-acid Schiff (PAS), Alcian blue (AB), and
mucicarmin techniques were employed to explore
the nature of the observed clear cell/signet ring cell
structures. The septa rather than the vacuoles
showed positivity for PAS indicating the existence of
glycogen (Fig. 2a, b). However, neither septa nor
vacuoles expressed AB or mucicarmine, suggesting
that neither mucin nor mucopolysaccharides existed
(data not shown). In line with the above results, the
septa expressed cytokeratin AE1/AE3, CK5/6, CK14,
and CK19 (Fig. 2c-f ). CK5/6 is a high molecular
weight cytokeratin wihic is usually up-regulated in
neoplasms of epithelial origin, including cSCC. Al-
though malignant cells did not express mutant p53,
they displayed strong and diffuse positivity for p63,
another member of the p53 family playing an im-
portant role in normal epithelial development and
differentiation (Fig. 2g, h). We also found the in-
creased expression of fibroblast growth factor
receptor-2 (FGFR2), a downstream effector of p63
(Fig. 2i). Nucleus immunoreactivity for Ki-67 is a
hallmark of high cell proliferation. In the sections,
less than 5 % of cancer cells expressed Ki-67 (Fig. 2j).
Malignant cells exhibited negativity for CK7, CK8,
CK18, CK20, P16, and c-erbB-2 (data not shown).
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HPV type-specific PCR and genotyping
DNA was extracted from FFPE tissue sections and puri-
fied using the TIANamp FFPE DNA Kit (TIANGEN,
Beijing, China). The operation was performed according
to the manufacturer’s protocol. Subsequently, HPV DNA
was amplified with the L1 consensus HPV PGMY09/
PGMY11 primer set as described previously [18]. PCR
was performed with a 25 ul reaction system, which con-
tained 1 ul (89 ng) DNA template and 0.75 ul DNA Taq
polymerase. Amplification was carried out for 40 cycles
in the CFX96 TouchTM Real-Time PCR Detection Sys-
tem (BIO-RAD, USA). HPV genotyping was performed
using the HPV GenoArray test kit (Hybribio, Chaozhou,
China), which identifies 15 high-risk HPV types (HPV
type 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66,
and 68) and 6 low-risk HPV types (HPV type 6, 11, 42,
43, 44, and 81) using flow-through hybridization and
gene chips. The result of genotyping indicated that this
patient was not infected with HPV (Fig. 3).
Discussion
Clear cell/signet-ring cell morphology is no longer re-
stricted to adenocarcinoma. A set of malignant or be-
nign squamous cell lesions has been demonstrated to
exhibit clear cell/signet-ring cell morphology. According
to our knowledge, this is the first report of the clear cell/
signet-ring cell variant of cSCC in the right thigh of a
patient with DM. In the cytoplasm of clear cells/signet-
ring cells, the septa of vacuoles displayed positivity for
PAS and cytokeratin may be composed of intermediate
filaments. Electron microscopy revealed that most of the
vacuoles contained moderate amounts of electron-dense
flocculent material, while the others are empty [19]. Fur-
ther studies demonstrate that inciting factors may pro-
mote the formation of dilated endoplasmic reticulum,
and that dilated endoplasmic reticula are among the
most important components of these vacuoles [20].
The etiology of the clear cell/signet-ring cell variant of
cSCC remains largely unknown. The role of UV radi-
ation in the carcinogenesis of cutaneous tumors has long
been understood and reported in the literature. Chronic
exposure to UV can cause cellular DNA mutations, such
as the various p53 mutations, and the accumulation of
genetic abnormalities eventually leads to the formation
of tumors [21]. Previous studies showed that clear cell
cSCC is spatially distributed mainly in the head and neck
Fig. 1 Clinical and histological findings of clear cell/signet ring cell cSCC. A mushroom-like lesion in right thigh was resected under local
anesthesia (a, b). Scars caused by chronic ulcer were observed adjacent to the lesion (a, black arrow). Clear cell/signet ring cell assembled thick
trabecula and solid nest (c, original magnification × 20). Scattered signet ring cells were observed (d, black arrow, original magnification × 400)
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Fig. 2 Histochemical and immunohistochemical profiles of clear cell/signet-ring cell SCC. The lesion was composed of diffused clear cells/signet
cells (a, original magnification × 400). The septa of clear cells/signet-ring cells in serial sections were positive for PAS (b, original magnification ×
400). They also expressed cytokeratin AE1/AE3, CK5/6, CK14, and CK19 (c–f, original magnification × 400). The lesion did not exhibit mutations of
p53 (g, original magnification × 400). P63 positivity was detected in the nuclei of malignant cells (h, original magnification × 400). Clear cells/
signet cells expressed strong-diffuse reactivity for FGFR2, a downstream effector of p63 (i, original magnification × 400). Less than 5 % of cancer
cells expressed Ki-67 (j, original magnification × 400)
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Fig. 3 The results of HPV type-specific PCR and genotyping indicated that the patient was negative for infection with HPV
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(Table 2) [2, 20, 22–27]. However, the sun-exposed time
of the thigh in this case was limited, raising the possibil-
ity that other molecular mechanisms may contribute to
the pathogenesis of clear cell/signet-ring cSCC.
The particularly strong association between HPV, es-
pecially high-risk varieties of HPV, and the carcinogen-
esis of cSCC has been confirmed [25]. HPV proteins E6
and E7 can promote the malignant transformation of
tumor cells through their interaction with the p53 pro-
tein and RB-susceptibility gene product (Rb). P53 is a
transcriptional factor that plays a critical role in the
regulation of the cell cycle, DNA repair, and apoptosis.
HPV can enhance the activity of the ubiquitin pathway
and promote the degradation of p53, this is a common
event in the initial stages of many malignant tumors [6].
Although p53 expression was not observed in malig-
nant clear cells/signet-ring cells in this case, we did not
detect any HPV infection in this patient, which suggests
that it is possible that different etiologic mechanisms
exist. However, immunohistochemistry in this case
confirmed the up-regulation of p63, another member of
the p53 family contributing to the proliferative potential
of epidermal progenitor cells [28]. TAp63 isoforms have
an effect on the commitment to stratification, while
ΔNp63 isoforms regulate the epidermal morphogenesis
at a later stage [29]. ΔNp63 not only directly competes
with other members of the p53 family in the inhibition
of consequent signaling pathways, but also regulates the
transcription of several genes involved in tumoreigen-
esis, such as IRF6, IKKα and FGFR2 (Fig. 4) [30–32].
Accumulating evidence supports the hypothesis that
DM, in addition to UV radiation and HPV infection,
may be involved in the carcinogenesis of cSCC. Pa-
tients with DM have an increased susceptibility to in-
fections and typically exhibit chronic ulcers in the
lower extremities. Cases of cutaneous SCC arising in
long-standing foot ulcer of diabetic patients have been
reported [12–15].
In this study, the clear cell/signet-ring cell variant of
cSCC also exhibited a close spatial and temporal
Fig. 4 Hypothesis regarding the involvement of type 2 DM in the pathogenesis of cSCC. Epidemiological studies suggest that hyperglycemia,
hyperinsulinemia, and immune disorders in patients with type 2 DM increase the risk of malignant transformation. DM-related chronic ulcer is proposed as
a precancerous lesion. Type 2 DM can enhance the expression of p63, which in turn activate the downstream element FGFR2. It may also increase the
secretion of FGF7 in stromal cells and affect FGFR2 through paracrine stimulates. Indirect evidence indicates that PI3K/AKT signaling may be involved and
contribute to the malignant transformation of squamous cell
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relationship with adjacent scars caused by a chronic
ulcer. Substantial research further demonstrates that
DM patients with oral SCC at advanced stages tended to
have a lower overall survival and a higher recurrence
rate compared to nondiabetic patients [16]. Epidemio-
logical studies consistently produce results that metfor-
min, a first-line drug for type 2 DM, can significantly
reduce the risk of many cancers. Metformin monother-
apy is associated with lower risk of breast and gastro-
intestinal cancers compared to treatment with
sulfonylurea (SU) derivatives, insulin or a combined SU
and metformin treatment [33, 34]. It can also signifi-
cantly improve the overall survival rate of patients with
head and neck cSCC [17].
Several hypotheses emerge regarding the underlying
molecular mechanisms. One study suggested that FGFR2,
a downstream effector of p63, may contribute to the pro-
gression from squamous cell dysplasia to cSCC [35]. Our
study supports this view since clear cells/signet-ring cells
exhibited strong-diffuse positivity for FGFR2 (Fig. 4). It is
worth noting that, in contrast to our findings, an elaborate
study took advantage of an established type 1 diabetic rat
model to demonstrate that up-regulated erb-B2 and erb-
B3 promoted cell proliferation and inhibited apoptosis
[36]. However, species, type of diabetes, and exact cSCC
region may explain these different conclusions.
Conclusion
cSCC tumors with clear cell/signet ring cell morphology
are extremely rare, and occur mainly in sun-exposed re-
gions of the body such as the head and neck. We reported
our analysis of the first known case of clear cell/signet ring
cell cSCC in the right thigh of a woman with type 2 DM.
Results of PAS and cytokeratin staining suggested that the
septa of cytoplasmic vacuoles in cancer cells were com-
posed of intermediate filaments. The negative result of the
HPV type-specific PCR and genotyping indicated that
HPV did not affect the malignant transformation of the le-
sion in this case. Although we have provided preliminary
evidence that DM may be involved in the development of
clear cell/signet ring cell cSCC via the p63/FGFR2 axis,
further research will be required to determine the exact
molecular mechanisms involved.
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